Figure 5From: Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers Plasma VEGF-A levels in metastatic RCC patients treated with sunitinib (ratio to baseline values). Vertical error bars represent SEM. Days 0, 45, 90, 135, 180 and 225 represent the beginning of cycles 1, 2, 3, 4, 5 and 6, respectively.Back to article page